Medical comorbidity, acute medical care use in late-life bipolar disorder: A comparison of lithium, valproate, and other pharmacotherapies

General Hospital Psychiatry

Volumn 37, Issue 6, 2015, Pages 528-532

  Rej, Soham ^a,b   Yu, Ching ^b   Shulman, Kenneth ^a   Herrmann, Nathan ^a   Fischer, Hadas D ^c   Fung, Kinwah ^c,d   Gruneir, Andrea ^c,d,e,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d WOMEN S COLLEGE HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bipolar disorder; Health care utilization; Lithium; Medical comorbidity; Older adults; Severe mental illness

Indexed keywords

LITHIUM SALT; NEUROLEPTIC AGENT; VALPROIC ACID; LITHIUM DERIVATIVE; TRANQUILIZER;

AGE DISTRIBUTION; AGED; ARTICLE; BIPOLAR DISORDER; CANADA; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; ELDERLY CARE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; OUTCOME ASSESSMENT; POPULATION RESEARCH; RETROSPECTIVE STUDY; SEX DIFFERENCE; COMPARATIVE STUDY; ONTARIO; SURVIVAL ANALYSIS;

AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; LITHIUM COMPOUNDS; MALE; ONTARIO; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VALPROIC ACID;

EID: 84946475780     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2015.07.001     Document Type: Article

References (34)

1. Gildengers A.G., Whyte E.M., Drayer R.A., Soreca I., Fagiolini A., Kilbourne A.M., et al. Medical burden in late-life bipolar and major depressive disorders. Am J Geriatr Psychiatry 2008, 16:194-200.
2. Lala S.V., Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol 2012, 25:20-25.
3. Hendrie H.C., Lindgren D., Hay D.P., Lane K.A., Gao S., Purnell C., et al. Comorbidity profile and healthcare utilization in elderly patients with serious mental illnesses. Am J Geriatr Psychiatry 2013, 21:1267-1276.
4. Sajatovic M., Bingham C.R., Campbell E.A., Fletcher D.F. Bipolar disorder in older adult inpatients. J Nerv Ment Dis 2005, 193:417-419.
5. Dols A., Sienaert P., van Gerven H., Schouws S., Stevens A., Kupka R., et al. The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review. Int Clin Psychopharmacol 2013, 28:287-296.
6. Rej S., Shulman K., Herrmann N., Harel Z., Fischer H.D., Fung K., et al. Prevalence and correlates of renal disease in older lithium users: a population-based study. Am J Geriatr Psychiatry 2014, 22:1075-1082.
7. Geddes J.R., Goodwin G.M., Rendell J., Azorin J.M., Cipriani A., Ostacher M.J., et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010, 375:385-395.
8. Shulman K.I., Rochon P., Sykora K., Anderson G., Mamdani M., Bronskill S., et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ 2003, 326:960-961.
9. Rej S, Shulman K, Herrmann N, Harel Z, Fischer HD, Fung K, et al. Farewell mood stabilizers? Psychotropic medication use patterns amongst discharged geriatric psychiatry inpatients with bipolar disorder, in press.
10. Strejilevich S.A., Urtueta-Baamonde M., Teitelbaum J., Martino D.J., Marengo E., Igoa A., et al. Clinical concepts associated with lithium underutilization in the treatment of bipolar disorder. Vertex 2011, 22:3-20.
11. Lee P.E., Sykora K., Gill S.S., Mamdani M., Marras C., Anderson G., et al. Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults. J Am Geriatr Soc 2005, 53:1374-1379.
12. Lipscombe L.L., Levesque L., Gruneir A., Fischer H.D., Juurlink D.N., Gill S.S., et al. Antipsychotic drugs and hyperglycemia in older patients with diabetes. Arch Intern Med 2009, 169:1282-1289.
13. Murray-Thomas T., Jones M.E., Patel D., Brunner E., Shatapathy C.C., Motsko S., et al. Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database. Cardiovasc Psychiatry Neurol 2013, 2013:247486.
14. Westman J., Hallgren J., Wahlbeck K., Erlinge D., Alfredsson L., Osby U. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open 2013, 3. 10.1136/bmjopen-2012-002373.
15. Shulman K.I., Sykora K., Gill S., Mamdani M., Bronskill S., Wodchis W.P., et al. Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study. J Clin Psychiatry 2005, 66:424-427.
16. Svendal G., Fasmer O.B., Engeland A., Berk M., Lund A. Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences. BMC Med 2012, 10:148.
17. Kishore B.K., Ecelbarger C.M. Lithium: a versatile tool for understanding renal physiology. Am J Physiol Renal Physiol 2013, 304:F1139-F1149.
18. Andreazza A.C., Gildengers A., Rajji T.K., Zuzarte P.M., Mulsant B.H., Young L.T. Oxidative stress in older patients with bipolar disorder. Am J Geriatr Psychiatry 2015, 23:314-319.
19. Martinsson L., Wei Y., Xu D., Melas P.A., Mathe A.A., Schalling M., et al. Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres. Transl Psychiatry 2013, 3:e261.
20. Fan M., Song C., Wang T., Li L., Dong Y., Jin W., et al. Protective effects of lithium chloride treatment on repeated cerebral ischemia-reperfusion injury in mice. Neurol Sci 2015, 36:315-321.
21. Kessing L.V., Sondergard L., Forman J.L., Andersen P.K. Lithium treatment and risk of dementia. Arch Gen Psychiatry 2008, 65:1331-1335.
22. Seitz D.P., Vigod S.N., Lin E., Gruneir A., Newman A., Anderson G., et al. Characteristics of older adults hospitalized in acute psychiatric units in Ontario: a population-based study. Can J Psychiatry 2012, 57:554-563.
23. Elovainio M., Ferrie J.E., Singh-Manoux A., Shipley M., Batty G.D., Head J., et al. Socioeconomic differences in cardiometabolic factors: social causation or health-related selection? Evidence from the Whitehall II Cohort Study, 1991-2004. Am J Epidemiol 2011, 174:779-789.
24. Scott D., Happell B. The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness. Issues Ment Health Nurs 2011, 32:589-597.
25. Almeida O.P., Hankey G.J., Yeap B.B., Golledge J., Norman P.E., Flicker L. Mortality among people with severe mental disorders who reach old age: a longitudinal study of a community-representative sample of 37,892 men. PLoS One 2014, 9:e111882.
26. Abitbol R., Rej S., Segal M., Looper K.J. Diabetes mellitus onset in geriatric patients: does long-term atypical antipsychotic exposure increase risk?. Psychogeriatrics 2015, 15:43-50.
27. Rej S., Li B.W., Looper K., Segal M. Renal function in geriatric psychiatry patients compared to non-psychiatric older adults: effects of lithium use and other factors. Aging Ment Health 2014, 18:847-853.
28. Rej S., Abitbol R., Looper K., Segal M. Chronic renal failure in lithium-using geriatric patients: effects of lithium continuation versus discontinuation - a 60-month retrospective study. Int J Geriatr Psychiatry 2013, 28:450-453.
29. McKnight R.F., Adida M., Budge K., Stockton S., Goodwin G.M., Geddes J.R. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012, 379:721-728.
30. Al Jurdi R.K., Marangell L.B., Petersen N.J., Martinez M., Gyulai L., Sajatovic M. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a "recovered" status in the systematic treatment enhancement program for bipolar disorder. Am J Geriatr Psychiatry 2008, 16:922-933.
31. Baldessarini R.J., Leahy L., Arcona S., Gause D., Zhang W., Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv 2007, 58:85-91.
32. Kilbourne A.M., Goodrich D.E., Lai Z., Post E.P., Schumacher K., Nord K.M., et al. Randomized controlled trial to assess reduction of cardiovascular disease risk in patients with bipolar disorder: the Self-Management Addressing Heart Risk Trial (SMAHRT). J Clin Psychiatry 2013, 74:e655-e662.
33. Hwang Y.J., Dixon S.N., Reiss J.P., Wald R., Parikh C.R., Gandhi S., et al. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Ann Intern Med 2014, 161:242-248.
34. Stessman J., Ginsberg G., Hammerman-Rozenberg R., Friedman R., Ronen D., Israeli A., et al. Decreased hospital utilization by older adults attributable to a home hospitalization program. J Am Geriatr Soc 1996, 44:591-598.